NTMT-03-B A Phase III Multicenter Randomized, Sham Controlled, Study to Determine the Safety and Efficacy of Renexus® in Macular Telangiectasia type 2.

Project: Research project

StatusActive
Effective start/end date7/3/187/2/21

Funding

  • Lowy Medical Research Institute Limited (NTMT03-B)